PBA
Paradigm Biocapital Advisors’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-73,149
| Closed | -$552K | – | 28 |
|
|
2022
Q2 | $552K | Sell |
73,149
-426,347
| -85% | -$3.22M | 0.11% | 23 |
|
|
2022
Q1 | $12.1M | Buy |
499,496
+240,750
| +93% | +$5.84M | 3.2% | 15 |
|
|
2021
Q4 | $8.33M | Buy |
+258,746
| New | +$8.33M | 2.38% | 17 |
|